About Heingrid Pharma Private Limited
Data last updated:
Heingrid Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 January 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2012PTC062000. Its GSTIN is 32AACCH8211P1ZI (Kerala).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Ebi Henry and Rajesh Pazhaniyappan.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at N0.27 3rd Cross Nrupathunga Layout Kottanur Dinne Main Road J.P. Nagar 7th Phase, Bangalore, Karnataka, India – 560078.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.31 Cr, a growth of 65% compared to the previous year. For the same year it recorded a net loss of ₹1.22 Lakh (net margin -0.9%) and EBITDA of -₹8,194 (EBITDA margin -0.1%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website heingridpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressN0.27 3rd Cross Nrupathunga Layout Kottanur Dinne Main Road J.P. Nagar 7th Phase, Bangalore, Karnataka, India – 560078
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Heingrid Pharma Private Limited
The main business activity of Heingrid Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Heingrid Pharma Private Limited FY 2022 filings available
Heingrid Pharma Private Limited reported revenue of ₹1.31 Cr (up 65% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Heingrid Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 65% growth in the latest year. EBITDA fell 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Heingrid Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹8,194 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.22 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Heingrid Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Heingrid Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Heingrid Pharma Private Limited
Heingrid Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Purple Remedies Private Limited | •••• | •••• | •••• | •••• | - | Rajkot, Gujarat, India |
| Medissist Pharma Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Quest Healthcare Private Limited | •••• | •••• | •••• | •••• | - | Bangalore, Karnataka, India |
| Tara Kika Enterprises Private Limited | •••• | •••• | •••• | •••• | - | Ankleshwar, Gujarat, India |
| Salax Chemicals Private Limited | •••• | •••• | •••• | •••• | - | Lucknow, Uttar Pradesh, India |
| Heingrid Pharma Private Limited this company | •••• | •••• | •••• | •••• | - | Bangalore, Karnataka, India |
| Lazerhead Pharma Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Zriza Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Bangalore, Karnataka, India |
| Hitzelberger Life Sciences Private Limited | •••• | •••• | •••• | •••• | - | Chennai, Tamil Nadu, India |
| Anand Kayakalp Pharmacy Private Limited. | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Klintoz Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Heingrid Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Heingrid Pharma Private Limited
Auditor information for Heingrid Pharma Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Board of Directors of Heingrid Pharma Private Limited
Heingrid Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ebi Henry | Director | 06 Jan 2012 | 14 Years 9 Months | Current |
| Rajesh Pazhaniyappan | Director | 06 Jan 2012 | 14 Years 9 Months | Current |
Ownership and Shareholding of Heingrid Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Heingrid Pharma Private Limited
Heingrid Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Heingrid Pharma Private Limited
Employment history and EPFO contributions of people linked to Heingrid Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Heingrid Pharma Private Limited
Heingrid Pharma Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Sameer Punanathottathil Muhamed Nazeer ceased to be Managing Director on 10 Feb 2015.
Credit Ratings, Litigation & Regulatory Alerts for Heingrid Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Heingrid Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Heingrid Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Heingrid Pharma Private Limited
Heingrid Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AACCH8211P1ZI | Kerala | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Heingrid Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Heingrid Pharma Private Limited
Heingrid Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 January 2012 (14+ years old) and is registered under CIN U24232KA2012PTC062000.
Heingrid Pharma reported revenue of ₹1.31 Cr for FY 2022 (up 65% YoY).
Heingrid Pharma has 2 current directors:
- Ebi Henry - Director
- Rajesh Pazhaniyappan - Director
Heingrid Pharma reported a net loss of ₹1.22 Lakh (net margin -0.9%) and EBITDA of -₹8,194 (EBITDA margin -0.1%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Heingrid Pharma is -1% over three years and 2% over five years. In the latest year (FY 2022) revenue rose 65%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Heingrid Pharma is 32AACCH8211P1ZI, registered in Kerala.
The CIN (Corporate Identification Number) of Heingrid Pharma is U24232KA2012PTC062000. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Heingrid Pharma was incorporated on 06 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Heingrid Pharma by revenue are Purple Remedies Private Limited, Medissist Pharma Private Limited, Quest Healthcare Private Limited, Tara Kika Enterprises Private Limited, Salax Chemicals Private Limited and 5 more, all in the Pharma industry (Formulations).
Sameer Punanathottathil Muhamed Nazeer ceased to be Managing Director on 10 Feb 2015. Ebi Henry was appointed as Director on 06 Jan 2012. Rajesh Pazhaniyappan was appointed as Director on 06 Jan 2012.
Heingrid Pharma can be reached through the website heingridpharma.com. Its registered office is in Bangalore, Karnataka, India.